The utility of Apc-mutant rats in modeling human colon cancer

DMM Disease Models and Mechanisms

Volumn 7, Issue 11, 2014, Pages 1215-1225

  Irving, Amy A ^a   Yoshimi, Kazuto ^b   Hart, Marcia L ^c   Parker, Taybor ^c   Clipson, Linda ^a   Ford, Madeline R ^a   Kuramoto, Takashi ^b   Dove, William F ^a   Amos Landgraf, James M ^a,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Allelic series; Animal models; APC; Colorectal cancer

Indexed keywords

APC PROTEIN;

ALLELISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENETICS; CANCER MODEL; CANCER PREVENTION; CHROMOSOME STRUCTURE; COLON; COLON CANCER; GENOTYPE; HUMAN; NONHUMAN; PHENOTYPE; RAT MUTANT; TUMOR GROWTH; ANIMAL; COLONIC NEOPLASMS; DISEASE MODEL; EARLY DIAGNOSIS; GENETICS; MUTATION; PATHOLOGY; RAT;

ANIMALIA; MUS; RATTUS;

ANIMALS; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; EARLY DIAGNOSIS; GENOTYPE; HUMANS; MUTATION; PHENOTYPE; RATS;

EID: 84919976801     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.016980     Document Type: Article

References (107)

1. American Cancer Society (2014a). What are the Key Statistics About Colorectal Cancer? Available from http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics, accessed on February 13, 2014.
2. American Cancer Society (2014b). What are the Risk Factors for Colorectal Cancer? Available from http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/ colorectal-cancer-risk-factors, accessed on February 13, 2014.
3. American Cancer Society (2014c). What are the Survival Rates for Colorectal Cancer by Stage? Available from http://www.cancer.org/cancer/colonandrectumcancer/ detailedguide/colorectal-cancer-survival-rates, accessed on February 13, 2014.
4. Amos-Landgraf, J. M., Kwong, L. N., Kendziorski, C. M., Reichelderfer, M., Torrealba, J., Weichert, J., Haag, J. D., Chen, K. S., Waller, J. L., Gould, M. N. et al. (2007). A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proc. Natl. Acad. Sci. USA 104, 4036-4041.
5. Amos-Landgraf, J. M., Irving, A. A., Hartman, C., Hunter, A., Laube, B., Chen, X., Clipson, L., Newton, M. A. and Dove, W. F. (2012). Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms. Proc. Natl. Acad. Sci. USA 109, 2060-2065.
6. Barouei, J., Moussavi, M. and Hodgson, D. M. (2012). Effect of maternal probiotic intervention on HPA axis, immunity and gut microbiota in a rat model of irritable bowel syndrome. PLoS ONE 7, e46051.
7. Berger, A. H., Knudson, A. G. and Pandolfi, P. P. (2011). A continuum model for tumour suppression. Nature 476, 163-169.
8. Bhatia, V. and Tandon, R. K. (2005). Stress and the gastrointestinal tract. J. Gastroenterol. Hepatol. 3, 332-339.
9. Bikle, D. D. (2014). Vitamin D and cancer: the promise not yet fulfilled. Endocrine 46, 29-38.
10. Brenner, H., Hoffmeister, M., Arndt, V. and Haug, U. (2007). Gender differences in colorectal cancer: implications for age at initiation of screening. Br. J. Cancer 96, 828-831.
11. Burt, R. W. (2000). Colon cancer screening. Gastroenterology 119, 837-853.
12. Byun, A. J., Hung, K. E., Fleet, J. C., Bronson, R. T., Mason, J. B., Garcia, P. E. and Crott, J. W. (2014). Colon-specific tumorigenesis in mice driven by Cre-mediated inactivation of Apc and activation of mutant Kras. Cancer Lett. 347, 191-195.
13. Centers for Disease Control and Prevention (2014). Colorectal Cancer Statistics. Available from http://www.cdc.gov/cancer/colorectal/statistics/index.htm, accessed on February 13, 2014.
14. Chan, A. T., Arber, N., Burn, J., Chia, W. K., Elwood, P., Hull, M. A., Logan, R. F., Rothwell, P. M., Schrör, K. and Baron, J. A. (2012). Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev. Res. (Phila.) 5, 164-178.
15. Crumeyrolle-Arias, M., Jaglin, M., Bruneau, A., Vancassel, S., Cardona, A., Daugé, V., Naudon, L. and Rabot, S. (2014). Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology 42, 207-217.
16. Cui, X., Ji, D., Fisher, D. A., Wu, Y., Briner, D. M. and Weinstein, E. J. (2011). Targeted integration in rat and mouse embryos with zinc-finger nucleases. Nat. Biotechnol. 29, 64-67.
17. De Vadder, F., Kovatcheva-Datchary, P., Goncalves, D., Vinera, J., Zitoun, C., Duchampt, A., Bäckhed, F. and Mithieux, G. (2014). Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84-96.
18. Dove, W. F., Shedlovsky, A., Clipson, L., Amos-Landgraf, J. M., Halberg, R. B., Krentz, K. J., Boehm, F. J., Newton, M. A., Adams, D. J. and Keane, T. M. (2014). A strategy to identify dominant point mutant modifiers of a quantitative trait. G3 (Bethesda) 4, 1113-1121.
19. Dunlop, M. G., Dobbins, S. E., Farrington, S. M., Jones, A. M., Palles, C., Whiffin, N., Tenesa, A., Spain, S., Broderick, P., Ooi, L. Y. et al.; Colorectal Tumour Gene Identification (CORGI) Consortium; Swedish Low-Risk Colorectal Cancer Study Group; COIN Collaborative Group (2012). Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nat. Genet. 44, 770-776.
20. Dutta, N., Sarotra, P., Gupta, S., Aggarwal, R. and Agnihotri, N. (2009). Mechanism of action of celecoxib on normal and acid-challenged gastric mucosa. Exp. Toxicol. Pathol. 61, 353-361.
21. Eaden, J. A., Abrams, K. R. and Mayberry, J. F. (2001). The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48, 526-535.
22. Eisner, R., Greiner, R., Tso, V., Wang, H. and Fedorak, R. N. (2013). A machine-learned predictor of colonic polyps based on urinary metabolomics. Biomed. Res. Int. 2013, 303982.
23. Eker, R. and Mossige, J. (1961). A dominant gene for renal adenomas in the rat. Nature 189, 858-859.
24. Fearnhead, N. S., Britton, M. P. and Bodmer, W. F. (2001). The ABC of APC. Hum. Mol. Genet. 10, 721-733.
25. Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., and Bray, F. (2014). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon, France, 2013. Available from http://globocan.iarc.fr, Accessed on February 13, 2014.
26. Foote, A. L. and Crystal, J. D. (2007). Metacognition in the rat. Curr. Biol. 17, 551-555.
27. Gardner, E. J. (1962). Follow-up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas and epidermal cysts. Am. J. Hum. Genet. 14, 376-390.
28. Gardner, E. J. and Plenk, H. P. (1952). Hereditary pattern for multiple osteomas in a family group. Am. J. Hum. Genet. 4, 31-36.
29. Geurts, A. M., Cost, G. J., Freyvert, Y., Zeitler, B., Miller, J. C., Choi, V. M., Jenkins, S. S., Wood, A., Cui, X., Meng, X. et al. (2009). Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325, 433.
30. Gondo, Y. (2013). Mouse models for human diseases by forward and reverse genetics. In Animal Models for the Study of Human Disease (ed. P. M. Conn), pp. 833-859. San Diego, CA: Elsevier Academic Press Inc.
31. min/+ mice. Mol. Cancer Res.
32. Guo, X., Brenner, M., Zhang, X., Laragione, T., Tai, S., Li, Y., Bu, J., Yin, Y., Shah, A. A., Kwan, K. et al. (2013). Whole-genome sequences of DA and F344 rats with different susceptibilities to arthritis, autoimmunity, inflammation and cancer. Genetics 194, 1017-1028.
33. Haigis, K. M. and Dove, W. F. (2002). A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity. Nat. Genet. 33, 33-39.
34. Halberg, F., Haus, E., Cardoso, S. S., Scheving, L. E., Kühl, J. F., Shiotsuka, R., Rosene, G., Pauly, J. E., Runge, W., Spalding, J. F. et al. (1973). Toward a chronotherapy of neoplasia: tolerance of treatment depends upon host rhythms. Experientia 29, 909-934.
35. Hinoi, T., Akyol, A., Theisen, B. K., Ferguson, D. O., Greenson, J. K., Williams, B. O., Cho, K. R. and Fearon, E. R. (2007). Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res. 67, 9721-9730.
36. Hirono, I., Kuhara, K., Hosaka, S., Tomizawa, S. and Golberg, L. (1981). Induction of intestinal tumors in rats by dextran sulfate sodium. J. Natl. Cancer Inst. 66, 579-583.
37. Howlader, N., Noone, A. M., Krapcho, M., Garshell, J., Neyman, N., Altekruse, S. F., Kosary, C. L., Yu, M., Ruhl, J., Tatalovich, Z. et al. (2013). SEER Cancer Statistics Review, 1975-2010. National Cancer Institute, Bethesda, MD, USA. http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
38. Hung, K. E., Maricevich, M. A., Richard, L. G., Chen, W. Y., Richardson, M. P., Kunin, A., Bronson, R. T., Mahmood, U. and Kucherlapati, R. (2010). Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment. Proc. Natl. Acad. Sci. USA 107, 1565-1570.
39. Huttlin, E. L., Chen, X., Barrett-Wilt, G. A., Hegeman, A. D., Halberg, R. B., Harms, A. C., Newton, M. A., Dove, W. F. and Sussman, M. R. (2009). Discovery and validation of colonic tumor-associated proteins via metabolic labeling and stable isotopic dilution. Proc. Natl. Acad. Sci. USA 106, 17235-17240.
40. Irving, A. A. (2014). Early Genetic and Molecular Signals and Environmental Modulators of Intestinal Neoplasia in the Pirc Rat. PhD dissertation, Molecular and Environmental Toxicology at the University of Wisconsin, Madison, WI, USA.
41. Irving, A. A., Halberg, R. B., Albrecht, D. M., Plum, L. A., Krentz, K. J., Clipson, L., Drinkwater, N., Amos-Landgraf, J. M., Dove, W. F. and DeLuca, H. F. (2011). Supplementation by vitamin D compounds does not affect colonic tumor development in vitamin D sufficient murine models. Arch. Biochem. Biophys. 515, 64-71.
42. Irving, A. A., Young, L. B., Pleiman, J. K., Konrath, M. J., Marzella, B., Nonte, M., Cacciatore, J., Ford, M. R., Clipson, L., Amos-Landgraf, J. M. et al. (2014). A simple, quantitative method to determine rat colonic tumor volume in vivo using alginate gel. Comp. Med. 64, 128-134.
43. Ivancic, M. M., Huttlin, E. L., Chen, X., Pleiman, J. K., Irving, A. A., Hegeman, A. D., Dove, W. F. and Sussman, M. R. (2013). Candidate serum biomarkers for early intestinal cancer using 15N metabolic labeling and quantitative proteomics in the ApcMin/+ mouse. J. Proteome Res. 12, 4152-4166.
44. Ivancic, M. M., Irving, A., Jonakin, K. G., Dove, W. F. and Sussman, M. R. (2014). The concentrations of EGFR, LRG1, ITIH4, and F5 in serum correlate with the number of colonic adenomas in ApcPirc/+ rats. Cancer Prev. Res. (Phila.) [Epub ahead of print] doi:10.1158/1940-6207.CAPR-14-0056.
45. Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T. and Tuveson, D. A. (2001). Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243-3248.
46. Jones, S., Chen, W. D., Parmigiani, G., Diehl, F., Beerenwinkel, N., Antal, T., Traulsen, A., Nowak, M. A., Siegel, C., Velculescu, V. E. et al. (2008). Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl. Acad. Sci. USA 105, 4283-4288.
47. Kinzler, K. W. and Vogelstein B. (1996). Lessons from hereditary colorectal cancer. Cell 87, 159-170.
48. Kochi, T., Shimizu, M., Shirakami, Y., Yoshimi, K., Kuramoto, T., Tanaka, T. and Moriwaki, H. (2014). Utility of Apc-mutant rats with a colitis-associated colon carcinogenesis model for chemoprevention studies. Eur. J. Cancer Prev. [Epub ahead of print] doi: 10.1097/CEJ.0000000000000063.
49. Kohler, E. M., Derungs, A., Daum, G., Behrens, J. and Schneikert, J. (2008). Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours. Hum. Mol. Genet. 17, 1978-1987.
50. Kosten, T. A., Huang, W. and Nielsen, D. A. (2014). Sex and litter effects on anxiety and DNA methylation levels of stress and neurotrophin genes in adolescent rats. Dev. Psychobiol. 56, 392-406.
51. Ladd, J. J., Busald, T., Johnson, M. M., Zhang, Q., Pitteri, S. J., Wang, H., Brenner, D. E., Lampe, P. D., Kucherlapati, R., Feng, Z. et al. (2012). Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. Cancer Prev. Res. (Phila.) 5, 655-664.
52. Largaespada, D. A. (2001). Haploinsufficiency for tumor suppression: the hazards of being single and living a long time. J. Exp. Med. 193, F15-F18.
53. Larsson, M., Asp, E., Johansson, A., Lü, X. C., Röhme, D. and Levan, G. (1998). Sublocalizing the centromeric region in linkage groups from three metacentric rat chromosomes by FISH. Mamm. Genome 9, 479-481.
54. Li, D., Qiu, Z., Shao, Y., Chen, Y., Guan, Y., Liu, M., Li, Y., Gao, N., Wang, L., Lu, X. et al. (2013a). Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat. Biotechnol. 31, 681-683.
55. Li, W., Teng, F., Li, T. and Zhou, Q. (2013b). Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat. Biotechnol. 31, 684-686.
56. Li, X. M., Mohammad-Djafari, A., Dumitru, M., Dulong, S., Filipski, E., Siffroi-Fernandez, S., Mteyrek, A., Scaglione, F., Guettier, C., Delaunay, F. et al. (2013c). A circadian clock transcription model for the personalization of cancer chronotherapy. Cancer Res. 73, 7176-7188.
57. Lidgard, G. P., Domanico, M. J., Bruinsma, J. J., Light, J., Gagrat, Z. D., Oldham-Haltom, R. L., Fourrier, K. D., Allawi, H., Yab, T. C., Taylor, W. R. et al. (2013). Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Clin. Gastroenterol. Hepatol. 11, 1313-1318.
58. Lin, D., Alborn, W. E., Slebos, R. J. and Liebler, D. C. (2013). Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma. J. Proteome Res. 12, 5996-6003.
59. Ma, Y., Zhang, X., Shen, B., Lu, Y., Chen, W., Ma, J., Bai, L., Huang, X. and Zhang, L. (2014). Generating rats with conditional alleles using CRISPR/Cas9. Cell Res. 24, 122-125.
60. Manna, S. K., Tanaka, N., Krausz, K. W., Haznadar, M., Xue, X., Matsubara, T., Bowman, E. D., Fearon, E. R., Harris, C. C., Shah, Y. M. et al. (2014). Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans. Gastroenterology 146, 1313-1324.
61. Mashimo, T. (2014). Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats. Dev. Growth Differ. 56, 46-52.
62. Mashimo, T., Yanagihara, K., Tokuda, S., Voigt, B., Takizawa, A., Nakajima, R., Kato, M., Hirabayashi, M., Kuramoto, T. and Serikawa, T. (2008). An ENU-induced mutant archive for gene targeting in rats. Nat. Genet. 40, 514-515.
63. Mashimo, T., Takizawa, A., Voigt, B., Yoshimi, K., Hiai, H., Kuramoto, T. and Serikawa, T. (2010). Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases. PLoS ONE 5, e8870.X
64. Mashimo, T., Kaneko, T., Sakuma, T., Kobayashi, J., Kunihiro, Y., Voigt, B., Yamamoto, T. and Serikawa, T. (2013). Efficient gene targeting by TAL effector nucleases coinjected with exonucleases in zygotes. Sci. Rep. 3, 1253.
65. McGovern, D. P., Gardet, A., Törkvist, L., Goyette, P., Essers, J., Taylor, K. D., Neale, B. M., Ong, R. T., Lagacé, C., Li, C. et al.; NIDDK IBD Genetics Consortium (2010). Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet. 42, 332-337.
66. Mikami, T., Yoshida, T., Numata, Y., Kikuchi, M., Araki, K., Nakada, N. and Okayasu, I. (2011). Invasive behavior of ulcerative colitis-associated carcinoma is related to reduced expression of CD44 extracellular domain: comparison with sporadic colon carcinoma. Diagn. Pathol. 6, 30.
67. Mollersen, L., Paulsen, J. E. and Alexander, J. (2004). Loss of heterozygosity and nonsense mutation in Apc in azoxymethane-induced colonic tumours in min mice. Anticancer Res. 24, 2595-2599.
68. Moser, A. R., Pitot, H. C. and Dove, W. F. (1990). A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324.
69. Murphy, G., Devesa, S. S., Cross, A. J., Inskip, P. D., McGlynn, K. A. and Cook, M. B. (2011). Sex disparities in colorectal cancer incidence by anatomic subsite, race and age. Int. J. Cancer 128, 1668-1675.
70. Nelson, S. and Näthke, I. S. (2013). Interactions and functions of the adenomatous polyposis coli (APC) protein at a glance. J. Cell Sci. 126, 873-877.
71. Nieuwenhuis, M. H. and Vasen, H. F. (2007). Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit. Rev. Oncol. Hematol. 61, 153-161.
72. Oshima, H. and Oshima, M. (2012). The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models. J. Gastroenterol. 47, 97-106.
73. Paul Olson, T. J., Hadac, J. N., Sievers, C. K., Leystra, A. A., Deming, D. A., Zahm, C. D., Albrecht, D. M., Nomura, A., Nettekoven, L. A., Plesh, L. K. et al. (2014). Dynamic tumor growth patterns in a novel murine model of colorectal cancer. Cancer Prev. Res. (Phila.) 7, 105-113.
74. Payne, S. R. and Kemp, C. J. (2005). Tumor suppressor genetics. Carcinogenesis 26, 2031-2045.
75. Peters, U., Jiao, S., Schumacher, F. R., Hutter, C. M., Aragaki, A. K., Baron, J. A., Berndt, S. I., Bézieau, S., Brenner, H., Butterbach, K. et al.; Colon Cancer Family Registry and the Genetics and Epidemiology of Colorectal Cancer Consortium (2013). Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology 144, 799-807.e24.
76. Pickhardt, P. J., Kim, D. H., Pooler, B. D., Hinshaw, J. L., Barlow, D., Jensen, D., Reichelderfer, M. and Cash, B. D. (2013). Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history. Lancet Oncol. 14, 711-720.
77. Plawski, A., Banasiewicz, T., Borun, P., Kubaszewski, L., Krokowicz, P., Skrzypczak-Zielinska, M. and Lubinski, J. (2013). Familial adenomatous polyposis of the colon. Hered. Cancer Clin. Pract. 11, 15.
78. Ponce de León, V., Mérillat, A. M., Tesson, L., Anegón, I. and Hummler, E. (2014). Generation of TALEN-mediated GRdim knock-in rats by homologous recombination. PLoS ONE 9, e88146.
79. Preston, S. L., Leedham, S. J., Oukrif, D., Deheregoda, M., Goodlad, R. A., Poulsom, R., Alison, M. R., Wright, N. A. and Novelli, M. (2008). The development of duodenal microadenomas in FAP patients: the human correlate of the Min mouse. J. Pathol. 214, 294-301.
80. Regula, J., Rupinski, M., Kraszewska, E., Polkowski, M., Pachlewski, J., Orlowska, J., Nowacki, M. P. and Butruk, E. (2006). Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N. Engl. J. Med. 355, 1863-1872.
81. Ritchie, K. J., Walsh, S., Sansom, O. J., Henderson, C. J. and Wolf, C. R. (2009). Markedly enhanced colon tumorigenesis in Apc(Min) mice lacking glutathione Stransferase Pi. Proc. Natl. Acad. Sci. USA 106, 20859-20864.
82. Rutte, C. and Taborsky, M. (2007). Generalized reciprocity in rats. PLoS Biol. 5, e196.
83. Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L. et al.; Inflammation and Host Response to Injury, Large Scale Collaborative Research Program (2013). Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl. Acad. Sci. USA 110, 3507-3512.
84. Smits, B. M., Mudde, J. B., van de Belt, J., Verheul, M., Olivier, J., Homberg, J., Guryev, V., Cools, A. R., Ellenbroek, B. A., Plasterk, R. H. et al. (2006). Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis. Pharmacogenet. Genomics 16, 159-169.
85. Suzui, M., Okuno, M., Tanaka, T., Nakagama, H. and Moriwaki, H. (2002). Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of beta-catenin mutation. Cancer Lett. 183, 31-41.
86. Trobridge, P., Knoblaugh, S., Washington, M. K., Munoz, N. M., Tsuchiya, K. D., Rojas, A., Song, X., Ulrich, C. M., Sasazuki, T., Shirasawa, S. et al. (2009). TGF-β receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a β-catenin-independent pathway. Gastroenterology 136, 1680-8.e7.
87. Valle, L., Serena-Acedo, T., Liyanarachchi, S., Hampel, H., Comeras, I., Li, Z., Zeng, Q., Zhang, H. T., Pennison, M. J., Sadim, M. et al. (2008). Germline allelespecific expression of TGFBR1 confers an increased risk of colorectal cancer. Science 321, 1361-1365.
88. van Boxtel, R., Gould, M. N., Cuppen, E. and Smits, B. M. (2010). ENU mutagenesis to generate genetically modified rat models. Methods Mol. Biol. 597, 151-167.
89. Vane, J. R. and Botting, R. M. (2003). The mechanism of action of aspirin. Thromb. Res. 110, 255-258.
90. Walz, S., Lorenzin, F., Morton, J., Wiese, K. E., von Eyss, B., Herold, S., Rycak, L., Dumay-Odelot, H., Karim, S., Bartkuhn, M. et al. (2014). Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature 511, 483-487.
91. Washington, M. K., Powell, A. E., Sullivan, R., Sundberg, J. P., Wright, N., Coffey, R. J. and Dove, W. F. (2013). Pathology of rodent models of intestinal cancer: progress report and recommendations. Gastroenterology 144, 705-717.
92. Weichert, J. P. (2004). Micro-computed tomography of mouse tumor models. In Mouse Models of Human Cancer (ed. E. Holland), pp. 339-348. Hoboken, NJ: John Wiley & Sons, Inc.
93. Wolfe, K. H. and Sharp, P. M. (1993). Mammalian gene evolution: nucleotide sequence divergence between mouse and rat. J. Mol. Evol. 37, 441-456.
94. Wood, P. A., Yang, X., Taber, A., Oh, E. Y., Ansell, C., Ayers, S. E., Al-Assaad, Z., Carnevale, K., Berger, F. G., Peña, M. M. et al. (2008). Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol. Cancer Res. 6, 1786-1793.
95. Worthey, E. A., Stoddard, A. J. and Jacob, H. J. (2010). Sequencing of the rat genome and databases. Methods Mol. Biol. 597, 33-53.
96. Yamazaki, K., Takazoe, M., Tanaka, T., Ichimori, T., Saito, S., Iida, A., Onouchi, Y., Hata, A. and Nakamura, Y. (2004). Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease. J. Hum. Genet. 49, 664-668.
97. Yan, H., Dobbie, Z., Gruber, S. B., Markowitz, S., Romans, K., Giardiello, F. M., Kinzler, K. W. and Vogelstein, B. (2002). Small changes in expression affect predisposition to tumorigenesis. Nat. Genet. 30, 25-26.
98. Yoshimi, K., Tanaka, T., Takizawa, A., Kato, M., Hirabayashi, M., Mashimo, T., Serikawa, T. and Kuramoto, T. (2009). Enhanced colitis-associated colon carcinogenesis in a novel Apc mutant rat. Cancer Sci. 100, 2022-2027.
99. Yoshimi, K., Hashimoto, T., Niwa, Y., Hata, K., Serikawa, T., Tanaka, T. and Kuramoto, T. (2012). Use of a chemically induced-colon carcinogenesis-prone Apc mutant rat in a chemotherapeutic bioassay. BMC Cancer 12, 448.
100. Yoshimi, K., Tanaka, T., Serikawa, T. and Kuramoto, T. (2013). Tumor suppressor APC protein is essential in mucosal repair from colonic inflammation through angiogenesis. Am. J. Pathol. 182, 1263-1274.
101. Yoshimi, K., Kaneko, T., Voigt, B. and Mashimo, T. (2014). Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR-Cas platform. Nat. Commun. 5, 4240.
102. Young, M., Ordonez, L. and Clarke, A. R. (2013). What are the best routes to effectively model human colorectal cancer? Mol. Oncol. 7, 178-189.
103. Zan, Y., Haag, J. D., Chen, K. S., Shepel, L. A., Wigington, D., Wang, Y. R., Hu, R., Lopez-Guajardo, C. C., Brose, H. L., Porter, K. I. et al. (2003). Production of knockout rats using ENU mutagenesis and a yeast-based screening assay. Nat. Biotechnol. 21, 645-651.
104. Zeineldin, M. and Neufeld, K. L. (2013). Understanding phenotypic variation in rodent models with germline Apc mutations. Cancer Res. 73, 2389-2399.
105. Zeineldin, M., Cunningham, J., McGuinness, W., Alltizer, P., Cowley, B., Blanchat, B., Xu, W., Pinson, D. and Neufeld, K. L. (2012). A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression. Oncogene 31, 2423-2437.
106. Zhang, T. Y., Labonté, B., Wen, X. L., Turecki, G. and Meaney, M. J. (2013). Epigenetic mechanisms for the early environmental regulation of hippocampal glucocorticoid receptor gene expression in rodents and humans. Neuropsychopharmacology 38, 111-123.
107. Zhao, S., Shetty, J., Hou, L., Delcher, A., Zhu, B., Osoegawa, K., de Jong, P., Nierman, W. C., Strausberg, R. L. and Fraser, C. M. (2004). Human, mouse, and rat genome large-scale rearrangements: stability versus speciation. Genome Res. 14 10A, 1851-1860.